GLUCAGEN

Manufacturer:

Boehringer Ingelheim

Name:

GLUCAGEN

HCPCS Code Descriptor:

Injection, glucagon hydrochloride, per 1 mg

Category:

J Code

HCPCS:

J1610

NDC(s):

72065-0140-11, 72065-0130-12, 72065-0131-11, 72065-0131-12, 72065-0130-11, 72065-0121-11, 72065-0121-12, 72065-0120-11, 72065-0120-12, 00597-0053-45, 00597-0260-10, 00548-5850-00, 00169-7065-15, 00002-8031-01

Primary Type:

Unclassified

Generic Status:

Multi-Source

Route of Administration:

Injection

About:

GLUCAGEN is an Unclassified drug manufactured by Boehringer Ingelheim and administered via the Injection route of administration. The J Code: J1610 is aligned to the drug GLUCAGEN.

Glucagen causes the body’s liver to release sugar, which in turn raises blood sugar levels. Glucagen is used to treat people that have high blood sugar and can slow down movements of the stomach intestines and colon. This medication is administered via subcutaneous injection, intravenous injection, and intramuscular injection. Glucagen is a generic medication that is manufactured by Novo Nordisk, Fresenius Kabi, Xeris Pharmaceuticals, and other manufacturers. Fresenius Kabi has its own HCPCS for Glucagen (J1611) separate from the generic HCPCS (J1610). Patient assistance programs for this medication can be found through Novo Nordisk.